Emonapride

奈莫必利

Report date: 2022/02/18 16:02:55
NME

Base Information

Drug NameEmonapride
Drug Alias Name尼莫纳地NemonaprideEmilaceYM-09151-2
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine receptors antagonistsSerotonin (5-HT) receptor antagonists
TargetsDopamine receptorsSerotonin (5-HT) receptor
Therapy Area/IndicationsSchizophrenia
Global Approved IndicationsSchizophrenia
Approved Indications in ChinaN/A
Original Approved Country/TerritoryJapan
Original Approved Date1991/01/01
Country/TerritoryJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesAstellas Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesAstellas Pharma Inc
Inactive CompaniesN/A
Active IndicationsSchizophrenia
Inactive IndicationsN/A

Other Information

ATC CodeN05A
Related LinksN/A